HOME >> BIOLOGY >> NEWS
Award winners announced for 2001 Merck/AAAS undergraduate science research program

San Francisco, CA 16 February 2001 The Merck Company Foundation and the American Association for the Advancement of Science today announced the names of the 15 universities and colleges that have won awards under the newly expanded program to provide research experiences in chemistry and biology for undergraduate students.

"Each award is worth $20,000 a year for up to three years, and we expect the funds to be used to build bridges between two crucial areas of science -- chemistry and biology," said Shirley Malcom, head of Education and Human Resources at AAAS. "Liberal arts colleges have played a key role in developing leaders in the sciences, and that is why we focus on those institutions."

The purpose of the program is to enhance undergraduate biology and chemistry education through undergraduate research experiences that emphasize the relationship between these scientific fields and to encourage students to pursue graduate education. In addition to supporting the undergraduates research efforts, the awards may provide funding for symposia, lecture series and workshops.

The Merck/AAAS program was launched in 1993 and, until this year, was limited to 12 northeastern/mid-Atlantic states. In 2001, however, the program was opened up to institutions around the country. The Merck Company Foundation has agreed to continue funding 15 awards each year through 2009.

This years winners are California State University in Sacramento, CA; Westminster College in New Wilmington, PA; Pacific Lutheran University in Tacoma, WA; Hobart and William Smith Colleges in Geneva, NY; Hope College in Holland, MI; Oakland University in Rochester, MI; Saint John's University in Collegeville, MN; St. Lawrence University in Canton, NY; St. Olaf College in Northfield, MN; State University of New York College at Fredonia in Fredonia, NY; University of South Alabama in Mobile, AL; University of Tennessee in Chattanooga, TN; University of Wisconsin in Superior, WI
'"/>

Contact: Cate Alexander
calexand@aaas.org
202-326-6431
American Association for the Advancement of Science
15-Feb-2001


Page: 1 2 3

Related biology news :

1. Gladstone investigator Mike McCune wins prestigious NIH Directors Pioneer Award
2. UT Southwestern biochemist honored with NIH Directors Pioneer Award
3. Award winning researchers reveal potential new role for Glivec
4. UMaine anthropologist wins Solon T. Kimball Award
5. Secretary of Energy announces seven E.O. Lawrence Award Winners
6. Martin Saunders to receive the James Flack Norris Award
7. Berkeley Lab soil scientist Margaret Torn receives Presidential Early Career Award
8. NJIT professor receives Presidential Award for breakthrough research with adult stem cells
9. Second call for proposals for the European Young Investigator Award
10. Virginia Tech professor honored with DeLaval Award
11. Institute for OneWorld Health nominated for the 2004 World Technology Awards

Post Your Comments:
(Date:1/22/2015)... Technology Showcase, Hall E -   EyeLock Inc. , a ... will showcase its EyeLock ID technology integrated in a 3D ... Oak Ridge National Laboratory (ORNL) at the 2015 ... authentication technology is being used to validate the driver and ...
(Date:1/22/2015)... , Jan. 16, 2015  A man-made form of ... and other mental capabilities in adults with mild cognitive ... study led by researchers at Wake Forest Baptist Medical ... diagnosed with amnesic mild cognitive impairment (MCI) or mild ...
(Date:1/22/2015)... YORK and POINT ROBERTS, Washington ... news source covering leading sectors including technology and tech stocks, ... Privacy marketplace featuring master pickpocket and security consultant Apollo ... is stolen and talks about the Wocket™ biometric smart wallet, ...
Breaking Biology News(10 mins):EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 3Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 2Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 3
(Date:2/27/2015)... , Feb. 27, 2015 A ... the NCATS rare-diseases portfolio " in Science ... new financing technique to reduce the risk associated ... and potentially unlock new levels of funding for ... product of a unique collaboration between scientists at ...
(Date:2/27/2015)... 27, 2015  Pfenex Inc. (NYSE MKT: PFNX), a ... therapeutics, today announced that it will be presenting at ... March 2 nd at 3pm PST. Patrick Lucy, chief ... discussing the current state of the biosimilar industry landscape ... For more information on CALBIO 2015 and ...
(Date:2/26/2015)... -- S&P Capital IQ (MHFI) announced today that it ... Therapeutics Holdings Inc . MabVax Therapeutics ... focused on the development of vaccine and antibody-based therapies ... cancer. MabVax has discovered a pipeline of human monoclonal ... by patients who have been immunized against targeted cancers. ...
(Date:2/26/2015)... 2015   Regulus Therapeutics Inc . (NASDAQ: ... and development of innovative medicines targeting microRNAs, today announced ... Chief Executive Officer of Regulus, will present a company ... Annual Healthcare Conference on Wednesday, March 4, 2015 at ... the Boston Marriott Copley Place.  The ...
Breaking Biology Technology:New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 2New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 3New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 5Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 2Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 3
Cached News: